These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 9478986)
21. Functional expression of equilibrative and concentrative nucleoside transporters in alveolar epithelial cells. Baba S; Yumoto R; Kawami M; Takano M Pharmazie; 2021 Sep; 76(9):416-421. PubMed ID: 34481531 [TBL] [Abstract][Full Text] [Related]
22. Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells. Fang X; Parkinson FE; Mowles DA; Young JD; Cass CE Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):457-65. PubMed ID: 8713072 [TBL] [Abstract][Full Text] [Related]
23. Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q). Vickers MF; Mani RS; Sundaram M; Hogue DL; Young JD; Baldwin SA; Cass CE Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):21-32. PubMed ID: 10085223 [TBL] [Abstract][Full Text] [Related]
24. Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy. Parker MD; Hyde RJ; Yao SY; McRobert L; Cass CE; Young JD; McConkey GA; Baldwin SA Biochem J; 2000 Jul; 349(Pt 1):67-75. PubMed ID: 10861212 [TBL] [Abstract][Full Text] [Related]
25. A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine. SenGupta DJ; Lum PY; Lai Y; Shubochkina E; Bakken AH; Schneider G; Unadkat JD Biochemistry; 2002 Feb; 41(5):1512-9. PubMed ID: 11814344 [TBL] [Abstract][Full Text] [Related]
26. Identification of Cys140 in helix 4 as an exofacial cysteine residue within the substrate-translocation channel of rat equilibrative nitrobenzylthioinosine (NBMPR)-insensitive nucleoside transporter rENT2. Yao SY; Sundaram M; Chomey EG; Cass CE; Baldwin SA; Young JD Biochem J; 2001 Jan; 353(Pt 2):387-93. PubMed ID: 11139404 [TBL] [Abstract][Full Text] [Related]
27. Development of a Novel HEK293 Cell Model Lacking Shahid N; Cromwell C; Hubbard BP; Hammond JR Drug Metab Dispos; 2024 Sep; 52(10):1094-1103. PubMed ID: 39054074 [TBL] [Abstract][Full Text] [Related]
28. Sensitivity to inhibition by N-ethylmaleimide: a property of nitrobenzylthioinosine-sensitive equilibrative nucleoside transporter of murine myeloma cells. Lee CW; Goh LB; Tu Y Biochim Biophys Acta; 1995 Aug; 1268(2):200-8. PubMed ID: 7662709 [TBL] [Abstract][Full Text] [Related]
29. L1210/B23.1 cells express equilibrative, inhibitor-sensitive nucleoside transport activity and lack two parental nucleoside transport activities. Vijayalakshmi D; Dagnino L; Belt JA; Gati WP; Cass CE; Paterson AR J Biol Chem; 1992 Aug; 267(24):16951-6. PubMed ID: 1512237 [TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of an L1210 cell line retaining the sodium-dependent carrier cif as its sole nucleoside transport activity. Crawford CR; Ng CY; Belt JA J Biol Chem; 1990 Aug; 265(23):13730-4. PubMed ID: 1974252 [TBL] [Abstract][Full Text] [Related]
31. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Griffiths M; Beaumont N; Yao SY; Sundaram M; Boumah CE; Davies A; Kwong FY; Coe I; Cass CE; Young JD; Baldwin SA Nat Med; 1997 Jan; 3(1):89-93. PubMed ID: 8986748 [TBL] [Abstract][Full Text] [Related]
32. Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2. Noguchi S; Takagi A; Tanaka T; Takahashi Y; Pan X; Kibayashi Y; Mizokami R; Nishimura T; Tomi M Biopharm Drug Dispos; 2021 Mar; 42(2-3):85-93. PubMed ID: 33426680 [TBL] [Abstract][Full Text] [Related]
33. Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. Sundaram M; Yao SY; Ng AM; Griffiths M; Cass CE; Baldwin SA; Young JD J Biol Chem; 1998 Aug; 273(34):21519-25. PubMed ID: 9705281 [TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells. Belt JA Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117 [TBL] [Abstract][Full Text] [Related]
35. Effects of inhibition of N-linked glycosylation by tunicamycin on nucleoside transport polypeptides of L1210 leukemia cells. Hogue DL; Hodgson KC; Cass CE Biochem Cell Biol; 1990 Jan; 68(1):199-209. PubMed ID: 2350487 [TBL] [Abstract][Full Text] [Related]
36. Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter. Bone DB; Hammond JR Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3325-32. PubMed ID: 17921321 [TBL] [Abstract][Full Text] [Related]
37. Retroviral transfer of the hENT2 nucleoside transporter cDNA confers broad-spectrum antifolate resistance in murine bone marrow cells. Patel DH; Allay JA; Belt JA; Sorrentino BP Blood; 2000 Apr; 95(7):2356-63. PubMed ID: 10733507 [TBL] [Abstract][Full Text] [Related]
38. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep. SenGupta DJ; Unadkat JD Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197 [TBL] [Abstract][Full Text] [Related]
39. Reduction of equilibrative nitrobenzylthioinosine-sensitive nucleoside transporter in tamoxifen-treated MCF-7 cells: an oestrogen-reversible phenomenon. Goh LB; Lee CW Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):31-6. PubMed ID: 9355731 [TBL] [Abstract][Full Text] [Related]
40. Contribution of equilibrative nucleoside transporter(s) to intestinal basolateral and apical transports of anticancer trifluridine. Takahashi K; Yoshisue K; Chiba M; Nakanishi T; Tamai I Biopharm Drug Dispos; 2018 Jan; 39(1):38-46. PubMed ID: 29055025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]